Container Closure Integrity (CCI)

Container Closure Integrity (CCI)
Product Description

Container closure integrity testing (CCIT) ensures adequate pharmaceutical packaging for your product. As an independent partner, OFI offers the optimal method of analysis for your packaging system.

Non-destructive testing of glass vials is performed by laser headspace analysis for oxygen ingress. Thus, the same samples can be monitored during stability studies under various conditions. Vials and bottles of all sizes are also subjected to the dye ingress method using methylene blue. For flexible plastic packaging systems, the bubble test allows to determine the smallest leaks. All tests are performed according to the USP <1207.2> under GMP.

In addition, we determine the moisture vapor transmission rate (MVTR) of plastic materials and their permeability by water vapor and oxygen.

Read more Show less

OFI Technologie & Innovation GmbH

  • AT
  • 2016
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Contract Service
Primary activities
Analytical Services
Laboratory Services
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Austria
More specifications Fewer specifications
Sales Markets
Show more Show less

OFI Technologie & Innovation GmbH

  • AT
  • 2016
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Contract Service
Primary activities
Analytical Services
Laboratory Services
View company profile

More Products from OFI Technologie & Innovation GmbH (2)

  • Packaging Release

    Product Packaging Release

    Pharmaceutical packaging serves an important protective function for your medicines and as such is a crucial part of your product.

    OFI performs all necessary tests for you to ensure its quality, from compendial testing, to CCI testing, and extractables & leachables testing. We offer ...
  • Biocompatibility

    Product Biocompatibility

    One focus of OFI is the evaluation of medical device biocompatibility. In accordance with the ISO 10993, a risk-based approach is used to obtain meaningful results and address product-specific requirements.

    Our testing expertise includes in vitro testing for cytotoxicity according to ...

OFI Technologie & Innovation GmbH resources (2)